SentiCare Inc.
Telehealth prescription monitoring with a personal touch
This article was originally published in Start Up
Executive Summary
SentiCare Inc.’s solution to the problem of prescription non-compliance is the PillStation, a telehealth medication adherence system used in the home setting that allows patients on complex medication regimens to more effectively self-administer their prescriptions. Using proprietary patent-pending hardware and software, PillStation, which looks like a diminutive wireless printer, incorporates a familiar pill tray design, a 24-hour remote monitoring center and personalized messaging to help patients manage their medication.
You may also be interested in...
Floelle Inc.
Floelle Inc. is developing a nonsurgical solution for women with stress and mixed urinary incontinence that it thinks will address the drawbacks of current technologies and provide a safe and effective solution that is convenient for patients. The Floelle device resides in the urethra where it allows normal urination, but a pressure-sensitive valve blocks the involuntary urine leaks caused by coughing, laughing, sneezing, and other activities that increase intra-abdominal pressure in women with stress urinary incontinence.
SA Ignite Inc.
The adoption of electronic health records involves reporting vast amounts of data to the government on an annual basis in order to meet meaningful use requirements and qualify for incentive payments, and that reporting can be complicated and time-consuming. That is where start-up health IT software company SA Ignite Inc. is looking to make a meaningful difference. It has developed cloud-based analytical tools designed to extract MU measures from EHRs and automate the reporting process, thus saving staff time and avoiding data entry errors.
Miromatrix Medical Inc.
Regenerative medicine start-up Miromatrix Medical is working to commercialize a technology known as perfusion decellularization. Its proprietary, patent-protected technology involves the decellularization of any vascularized tissue, up to and including whole organs, leaving behind a completely preserved native scaffold (matrix) that retains the original architecture, mechanical properties and vascular network of the tissue or organ. This scaffold can then be repopulated with vascular- and organ-specific regenerative cells and, under controlled conditions in a bioreactor, a biocompatible, functioning organ or tissue is created.